<DOC>
	<DOCNO>NCT01043926</DOCNO>
	<brief_summary>This study determine whether plasma concentration-time profile pharmacokinetics ( PK ) suvorexant ( MK-4305 ) participant moderate mild hepatic insufficiency similar observe healthy participant .</brief_summary>
	<brief_title>Pharmacokinetics Suvorexant Participants With Hepatic Insufficiency ( MK-4305-017 )</brief_title>
	<detailed_description>Study Design : This study plan enroll 16 participant Part I ( 8 participant moderate hepatic insufficiency 8 healthy participant ) 16 participant Part II ( 8 participant mild hepatic insufficiency 8 healthy participant ) . Part II conduct primary hypothesis meet significant difference PK suvorexant healthy participant moderate hepatic insufficiency participant Part I .</detailed_description>
	<mesh_term>Hepatic Insufficiency</mesh_term>
	<mesh_term>Suvorexant</mesh_term>
	<criteria>Inclusion Criteria Hepatic Insufficiency Participants : Females reproductive potential must negative pregnancy test agree use ( and/or partner use ) two acceptable method birth control Body Mass Index ( BMI ) ≤35 kg/m^2 prior start study Diagnosis stable hepatic insufficiency Smoking restrict ≤10 cigarette per day Inclusion Criteria Healthy Matched Participants : Females reproductive potential must negative pregnancy test agree use ( and/or partner use ) two acceptable method birth control BMI within approximately 20 % his/her hepatic participant Participant healthy Participant match race , gender , age ( +/ 5 yr ) his/her hepatic participant enrol study Smoking restrict ≤10 cigarette per day Exclusion Criteria Hepatic Insufficiency Participants : Participant mentally legally incapacitated History clinically significant psychiatric disorder last 5 10 year Participant history illness relate his/her hepatic insufficiency History persistent sleep abnormality occur least three ( 3 ) month Participant history stroke , chronic seizure , major neurological disorder History clinically significant hematological , immunological , renal , respiratory , genitourinary abnormality , uncomplicated kidney stone childhood asthma History cancer History cataplexy Participant nursing mother Participant consume &gt; 3 serving alcohol day Participant consume &gt; 6 caffeine serving day History multiple and/or severe allergy Participant currently use history illegal drug use Participant travel across 3 time zone within 2 week study participation Participant work night shift able avoid night shift work within 1 week treatment visit Exclusion Criteria Healthy Matched Participants : Participant mentally legally incapacitate . History clinically significant psychiatric disorder last 5 10 year . Participant history illness History persistent sleep abnormality occur least three ( 3 ) month Participant history stroke , chronic seizure , major neurological disorder History clinically significant endocrine , gastrointestinal , cardiovascular , hematological , immunological , renal , respiratory , genitourinary abnormality , uncomplicated kidney stone childhood asthma History cancer History cataplexy Participant nursing mother Participant consume &gt; 3 serving alcohol day Participant consume &gt; 6 caffeine serving day History multiple and/or severe allergy Participant currently use history illegal drug use Participant history chronic and/or active hepatic disease Participant travel across 3 time zone within 2 week study participation Participant work night shift able avoid night shift work within 1 week treatment visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Hepatic Insufficiency</keyword>
</DOC>